Data-Driven Insights into Medical Cannabis Efficiency

Data from 8,831 medical cannabis patients in Germany (November 2025)

Economic Impact

€3.7B

Annual economic benefit to German economy

58%

Reduction in annual sick days

From 37.6 to 15.7 days per year

20.6%

Returned to work

Previously long-term disabled patients

Medication Reduction (Deprescribing)

62.8%

Completely stopped another medication

28%

Significantly reduced dosage of other medications

Up to 50%

Reduction in opioid dosing

Work Performance & Quality of Life

68% Work more efficiently

Due to improved sleep quality

42.1% Improved cognitive function

At work after starting treatment

54.3% Increased work efficiency

Due to reduced symptom intensity

85.8% Significant QoL improvement

Since starting cannabis treatment

Safety Profile

69.9%

Reported fewer side effects vs. conventional sleep medications

85.8% reported significant improvement in quality of life

Social Challenges

Despite proven benefits, 50%+ of patients hide treatment from colleagues due to stigma. 22.5% who disclosed regretted it due to discrimination.

Source: BPC - Bundesverband pharmazeutischer Cannabinoidunternehmen e. V., Germany, November 2025. Report: "Impact of Medical Cannabis on Illness-Related Absenteeism at the Workplace" (n=8,831)